These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4296229)

  • 41. Cyclophosphamide in disseminated bronchial carcinoma.
    Cameron SJ; Grant IW; Crompton GK
    Scott Med J; 1974 Mar; 19(2):81-6. PubMed ID: 4365318
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
    Castberg T; Kruse-Blinkenberg HO
    Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fiberoptic bronchoscopy-gold vapor laser treatment of bronchogenic carcinoma].
    Deng WW
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):25-6, 63. PubMed ID: 2848635
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cytostatic polychemotherapy regimens. II. Bronchopulmonary neoplasms].
    Bild E; Carasievici E
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):177-82. PubMed ID: 1963699
    [No Abstract]   [Full Text] [Related]  

  • 45. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bronchial arterial infusion therapy for inoperable bronchogenic carcinoma (author's transl)].
    Ogawa J; Ishihara T; Kikuchi K; Inoue H; Fukai S
    Kyobu Geka; 1977; 30(8):640-5. PubMed ID: 904116
    [No Abstract]   [Full Text] [Related]  

  • 47. [Selective perfusion of the bronchial arteries in the treatment of bronchopulmonary neoplasms].
    Buscioni-Francalanci G; Balatresi P
    Minerva Med; 1966 Sep; 57(72):2906-10. PubMed ID: 5917932
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract]   [Full Text] [Related]  

  • 50. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 51. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
    Richards F; Pajak TF; Cooper MR; Spurr CL
    Cancer Chemother Rep; 1973; 57(4):419-22. PubMed ID: 4357670
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemotherapeutic drugs marked with radioactive isotopes.
    Monod O; Rymer M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):245-9. PubMed ID: 4125742
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)].
    Klastersky J; Sculier JP
    Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 55. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Photodynamic therapy of bronchial cancer].
    Häussinger K; Huber RM; Krug M; Breyer G; Baumgartner R; Beyer W; Jocham D; Stepp H; Unsöld E; Sroka R
    Pneumologie; 1990 Mar; 44(3):687-93. PubMed ID: 2326245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclophosphamide plus emetine in lung cancer.
    Street EW
    Lancet; 1972 Aug; 2(7773):381-2. PubMed ID: 4114753
    [No Abstract]   [Full Text] [Related]  

  • 58. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 59. Double blood supply of bronchogenic carcinoma from multiple arteries.
    Hellekant C; Jonsson K
    Acta Radiol Diagn (Stockh); 1981; 22(4):403-6. PubMed ID: 7331852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.